Literature DB >> 981969

Reversible activation of proactivator (factor B) of the alternative pathway without cleavage of the molecule.

N K Day, R D Schreiber, O Götze, H J Müller-Eberhard.   

Abstract

The serum of a patient (M.C.) with chronic glomerulonephritis and renal deposits of IgA, C3, and properdin converted C3 on overnight exposure of 0 degrees C. The cold reaction was dependent on immunoglobulin, initiating factor, Factors B and D, and magnesium but not on properdin. Factor B, the C3-cleaving enzyme in this reaction, was used in zymogen form. After participation in this rection, Factor B zymogen in M.C. serum could be fully activated by cobra venom factor (CVF) at 37 degrees C. That activation without fragmentation was not due to an abnormal form of Factor B was shown by its typical cleavage on incubation of MC. serum with CVF or C3b or after depletion of C3b inactivator. The evidence indicates that in the cold reaction only the initial C3 convertase of the alternative parhway is formed and that this enzyme is responsible for the observed C3 consumption.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 981969     DOI: 10.1111/j.1365-3083.1976.tb03021.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

Review 1.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

2.  Animal model of human disease. Lymphocytic thyroiditis. Autoimmune thyroiditis in rats induced by thymectomy and irradiation.

Authors:  W J Penhale; S A Ahmed
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

3.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

Review 4.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

5.  Defective activation of the alternative pathway of complement in patients with homozygous C2 deficiency: studies in two unrelated families.

Authors:  R Schwertz; E Esser; R A Seger; A Rubinstein; G Hauptmann; V Wahn
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.